Search results
Results from the WOW.Com Content Network
Additionally, Evergreen Treatment Services will get $1.35 million to operate a mobile clinic, bringing medications to people where they are.
Additionally, Evergreen Treatment Services will get $1.35 million to operate a mobile clinic, bringing medications to people where they are. The money comes from a federal grant and is part of a $27 million investment pledged by Harrell’s administration to address the fentanyl crisis.
In October 2011, LEAD was launched in Seattle as a four-year pilot program, with private foundation funding of $950,000 a year. [5] The multi-agency collaboration included the Seattle Police Department, the King County Sheriff’s Office, the King County Prosecutor, the Seattle City Attorney, the Washington State Department of Corrections, Evergreen Treatment Services, the Washington American ...
The system was formed in 1967 and opened its first hospital, originally named the Evergreen General Hospital, in 1972. It was renamed to Evergreen Healthcare Medical Group in 1996 and shortened to EvergreenHealth in 2012. A second hospital in Monroe was added in 2014 through a merger with the existing Valley General Hospital, which opened in 1949.
At Every Child Pediatrics, Luzietti says around 7,000 of her patients lost Medicaid, and the percentage of uninsured patients seeking treatment at her clinics grew from 8% to 15% during the unwinding.
Smith eventually diversified his business holdings by creating Evergreen Aviation and Ground Logistics Enterprises, Evergreen Sales and Leasing, Evergreen Humanitarian and Relief Services, Evergreen Agricultural Enterprises, and Evergreen Unmanned Services. At its peak, Evergreen was doing business in more than 100 countries with a fleet of ...
America's opioid crisis has only worsened over the years, and a new study bolsters calls for medication-assisted treatment (MAT) to manage resulting substance use disorders.
Most treatment programs haven’t accepted medically assisted treatments such as Suboxone because of “myths and misinformation,” said Robert Lubran, the director of the pharmacological therapy division at the federal Substance Abuse and Mental Health Services Administration.